Funtleyder on Lilly's Alzheimer's Drug

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Oct. 9 (Bloomberg) -- Les Funtleyder, president of the investment advisory division at Poliwogg, talks about Eli Lilly & Co.'s experimental Alzheimer's treatment, the Alzheimer's drug market and the outlook for Lilly and PDL BioPharma Inc. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Shannon Pettypiece also speaks. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change